Gene expression profiles of the oestrogen receptor in breast cancer

被引:0
作者
Kok, M. [1 ]
Linn, S. C. [2 ,3 ]
机构
[1] Tergooi Hosp, Div Internal Med, Hilversum, Netherlands
[2] Netherlands Canc Inst, Div Med Oncol, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands
关键词
Breast cancer; oestrogen receptor; endocrine treatment; gene expression profiling; micro-array; NEOADJUVANT ENDOCRINE THERAPY; GENOME-WIDE ANALYSIS; ADJUVANT TAMOXIFEN; PROGESTERONE-RECEPTOR; POSTMENOPAUSAL WOMEN; MOLECULAR CLASSIFICATION; AROMATASE INHIBITORS; RESISTANCE; CELLS; ALPHA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Breast cancer is a heterogeneous disease and existing clinicopathological classifications do not fully capture the diversity in clinical disease course. Since the oestrogen receptor (ER) plays a central role in the crosstalk between different signalling pathways in breast cancer, the expression of this receptor is important for the behaviour of breast cancer cells and is reflected in gene expression patterns of breast tumours. High throughput analysis of gene expression of breast cancer has increased the insights into ER signalling, including its relation with disease outcome and therapy response. Expression of ER and its numerous downstream targets are driving patterns of gene expression and dominate unsupervised analyses in the breast cancer specimens studied to date, regardless of microarray platform or statistical approach. This paper reviews gene expression studies either attempting to unravel the functional effect of ER or describing the gene expression profiles driven by ER in breast tumours. In addition, the development of molecular signatures predicting response to endocrine treatment will be discussed.
引用
收藏
页码:291 / 302
页数:12
相关论文
共 116 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]  
Abe O, 1998, LANCET, V352, P930
[3]   Endocrine-responsive breast cancer and strategies for combating resistance [J].
Ali, S ;
Coombes, RC .
NATURE REVIEWS CANCER, 2002, 2 (02) :101-+
[4]   Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database [J].
Anderson, WF ;
Chatterjee, N ;
Ershler, WB ;
Brawley, OW .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 (01) :27-36
[5]  
[Anonymous], 1996, Lancet, V348, P1189
[6]  
Beatson GT., 1896, LANCET, V148, P104
[7]   RELATIONSHIP BETWEEN ESTROGEN-RECEPTOR VALUES AND CLINICAL DATA IN PREDICTING THE RESPONSE TO ENDOCRINE THERAPY FOR PATIENTS WITH ADVANCED BREAST-CANCER [J].
BYAR, DP ;
SEARS, ME ;
MCGUIRE, WL .
EUROPEAN JOURNAL OF CANCER, 1979, 15 (03) :299-310
[8]   Clinical application of the 70-gene profile: The MINDACT trial [J].
Cardoso, Fatima ;
Van't Veer, Laura ;
Rutgers, Emiel ;
Loi, Sherene ;
Mook, Stella ;
Piccart-Gebhart, Martine J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) :729-735
[9]   Genome-wide analysis of estrogen receptor binding sites [J].
Carroll, Jason S. ;
Meyer, Clifford A. ;
Song, Jun ;
Li, Wei ;
Geistlinger, Timothy R. ;
Eeckhoute, Jerome ;
Brodsky, Alexander S. ;
Keeton, Erika Krasnickas ;
Fertuck, Kirsten C. ;
Hall, Giles F. ;
Wang, Qianben ;
Bekiranov, Stefan ;
Sementchenko, Victor ;
Fox, Edward A. ;
Silver, Pamela A. ;
Gingeras, Thomas R. ;
Liu, X. Shirley ;
Brown, Myles .
NATURE GENETICS, 2006, 38 (11) :1289-1297
[10]   Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1 [J].
Carroll, JS ;
Liu, XS ;
Brodsky, AS ;
Li, W ;
Meyer, CA ;
Szary, AJ ;
Eeckhoute, J ;
Shao, WL ;
Hestermann, EV ;
Geistlinger, TR ;
Fox, EA ;
Silver, PA ;
Brown, M .
CELL, 2005, 122 (01) :33-43